Doptelet and Platelet disorder - a phase IV clinical study of FDA data

Summary:

Platelet disorder is reported as a side effect among people who take Doptelet (avatrombopag maleate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Vitamin B12, and have Thrombocytopenia.

The phase IV clinical study analyzes which people have Platelet disorder when taking Doptelet. It is created by eHealthMe based on reports of 1,388 people who have side effects when taking Doptelet from the FDA, and is updated regularly.

What is Doptelet?

Doptelet has active ingredients of avatrombopag maleate. eHealthMe is studying from 1,389 Doptelet users. Check the latest studies of Doptelet.

What is Platelet disorder?

Platelet disorder is found to be associated with 317 drugs and 431 conditions by eHealthMe. Check the latest studies of Platelet disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

1,388 people reported to have side effects when taking Doptelet.
Among them, 11 people (0.79%) have Platelet disorder.

Could Doptelet cause Platelet disorder?

Among these 11 people:

How long have people been on Doptelet when they have Platelet disorder? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Platelet disorder when taking Doptelet? *

  • female: 72.73 %
  • male: 27.27 %

What is the age of people who have Platelet disorder when taking Doptelet? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Doptelet? *

  1. Vitamin D3: 2 people, 18.18%
  2. Lantus: 2 people, 18.18%
  3. Vitamin B12: 2 people, 18.18%
  4. Metformin: 1 person, 9.09%
  5. Aspirin: 1 person, 9.09%
  6. Breo Ellipta: 1 person, 9.09%
  7. Claritin: 1 person, 9.09%
  8. Cozaar: 1 person, 9.09%
  9. Crestor: 1 person, 9.09%
  10. Decadron: 1 person, 9.09%

What are other side effects people have besides Platelet disorder? *

  1. Pigmentation Disorder (disturbances of human skin colour): 2 people, 18.18%
  2. Thrombocytopenia (decrease of platelets in blood): 1 person, 9.09%
  3. Haematochezia (passage of stools containing blood): 1 person, 9.09%
  4. Drug Ineffective: 1 person, 9.09%

What are the existing conditions these people have? *

  1. Thrombocytopenia (decrease of platelets in blood): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Doptelet and have Platelet disorder?

- Check whether Platelet disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Doptelet:

Platelet disorder treatments and more:

How severe was Platelet disorder and when was it recovered:

Expand to all the drugs that have ingredients of avatrombopag maleate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Doptelet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Platelet disorder:

Browse all the conditions that are associated with Platelet disorder:


How the study uses the data?

The study uses data from the FDA. It is based on avatrombopag maleate (the active ingredients of Doptelet) and Doptelet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: